Skip to Content
ETFs

ETF Series Solutions Trust Range Cancer Therapeutics ETF

CNCR
$--
Today’s Change
-- (--)

Snapshot
*

Inception Date
Oct 13, 2015
Expense Ratio
0.79%
Type
US Equities
Fund Owner
Exchange Traded Concepts
Volume (1m avg. daily)
$12,640
AUM
$8,868,000
Associated Index
Loncar Cancer Immunotherapy Index
Inverse/Leveraged
No
Passive/Active
Passive
Fractionable on Composer
No
Prospectus
View

Top 10 Holdings

TNGX
Tango Therapeutics Inc
4.02%
HCM
HUTCHMED (China) Limited - ADR
1.85%
EQRX
EQRx Inc
1.67%
RVMD
Revolution Medicines Inc
1.66%
n/a
Cash & Other
1.64%
EXEL
Exelixis Inc
1.59%
IDYA
Ideaya Biosciences Inc
1.56%
MRTX
Mirati Therapeutics Inc
1.54%
SGEN
Seagen Inc
1.54%
REGN
Regeneron Pharmaceuticals, Inc.
1.53%
Invest with CNCR

What is CNCR?

The Loncar Cancer Immunotherapy ETF seeks to track the LCINDX index. It is made up of a basket of companies that develop therapies to treat cancer by harnessing the body s own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become the foundational treatment for cancer over the next ten years. A sector ETF focusing on a unique technology like cancer immunotherapy allows investors to focus on interest areas more precisely than broad indices. LCINDX is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.

ETFs related toCNCR

ETFs correlated to CNCR include LABU, XBI, GNOM

CNCR
ETF Series Solutions Trust - Range Cancer Therapeutics ETF
LABU
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
XBI
SPDR Series Trust - SPDR Biotech ETF
GNOM
Global X Funds - Global X Genomics & Biotechnology ETF
IBB
BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF
ARKG
ARK Investment Management LLC - ARK Genomic Revolution ETF
FBT
First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund
IWC
BlackRock Institutional Trust Company N.A. - iShares Micro-Cap ETF
XPH
SPDR Series Trust - SPDR Pharmaceuticals ETF
VBK
Vanguard Group, Inc. - Vanguard Small Cap Growth ETF
VTWG
Vanguard Group, Inc. - Vanguard Russell 2000 Growth Index ETF

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • •Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • •Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • •Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

Automated Strategies
Related toCNCR

#GLOBE

Follow the Global Trend

Category

Momentum, Lever Up, Go Global, Diversification

Risk Rating

Moderate

Create your own algorithmic trading strategy with CNCR using Composer

News Related to CNCR

3 ETFs For More Moderna Bets

May 19, 2020 • by ETF Professor
3 ETFs For More Moderna Bets
Read

Hone In On Health Care In China With This New ETF

Aug 16, 2018 • by ETF Professor
Read

FAQ

CNCR is a US Equities ETF. The Loncar Cancer Immunotherapy ETF seeks to track the LCINDX index. It is made up of a basket of companies that develop therapies to treat cancer by harnessing the body s own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become the foundational treatment for cancer over the next ten years. A sector ETF focusing on a unique technology like cancer immunotherapy allows investors to focus on interest areas more precisely than broad indices. LCINDX is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.

CNCR tracks the Loncar Cancer Immunotherapy Index.

No, CNCR is not actively managed. It is passively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

Yes, CNCR is passively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on CNCR is -0.0872%. This is the percent change in the value of CNCR over the most recent 1-month period. The 3-month return on CNCR is -0.1474%. This is the percent change in the value of CNCR over the most recent 3-month period.

The standard deviation of CNCR for the past year is 0.2911%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to CNCR include XLI, XLY, and XLV.

ETFs correlated to CNCR include LABU, XBI, and GNOM.

ETFs that are inversely correlated to CNCR include LABD, SRTY, and TZA.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.